Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

Register to chat with this document.

RNS - Lucentis biosimilar FYB201/Ranivisio (ranibizumab) approved in Brazil

Company: Formycon AG Date: 2025-06-05 Language: English Register to download

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method: